Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory

Nature Neuroscience

Volumn 18, Issue 3, 2015, Pages 423-439

  Orr, Anna G ^a,b   Hsiao, Edward C ^b,c   Wang, Max M ^a   Ho, Kaitlyn ^a   Kim, Daniel H ^a   Wang, Xin ^a   Guo, Weikun ^a   Kang, Jing ^a   Yu, Gui Qiu ^a   Adame, Anthony ^d,e   Devidze, Nino ^a   Dubal, Dena B ^a,b   Masliah, Eliezer ^d,e   Conklin, Bruce R ^b,c   Mucke, Lennart ^a,b  

^a GLADSTONE INSTITUTE OF NEUROLOGICAL DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; AMYLOID PRECURSOR PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; ACTIVITY REGULATED CYTOSKELETAL-ASSOCIATED PROTEIN; CYTOSKELETON PROTEIN; INDOLE DERIVATIVE; NERVE PROTEIN; SEROTONIN 4 RECEPTOR; SEROTONIN ANTAGONIST; SULFONAMIDE;

AGED; AGING; ALZHEIMER DISEASE; AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARC GENE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; IMMEDIATE EARLY GENE; LEARNING; LONG TERM MEMORY; MOUSE; NEUROFIBRILLARY TANGLE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPATIAL MEMORY; WORKING MEMORY; ANIMAL; C57BL MOUSE; DRUG EFFECTS; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GENETICS; MAZE TEST; METABOLISM; PATHOLOGY; PHYSIOLOGY; RECOGNITION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CYTOSKELETAL PROTEINS; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INDOLES; MAZE LEARNING; MEMORY, LONG-TERM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; RECEPTOR, ADENOSINE A2A; RECEPTORS, SEROTONIN, 5-HT4; RECOGNITION (PSYCHOLOGY); SEROTONIN ANTAGONISTS; SIGNAL TRANSDUCTION; SULFONAMIDES;

EID: 84923833075     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3930     Document Type: Article

References (85)

1. Fredholm, B.B., IJzerman, A.P., Jacobson, K.A., Klotz, K.N. & Linden, J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527-552 (2001).
2. Burnstock, G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87, 659-797 (2007).
3. Bogenpohl, J.W., Ritter, S.L., Hall, R.A. & Smith, Y. Adenosine A2A receptor in the monkey basal ganglia: ultrastructural localization and colocalization with the metabotropic glutamate receptor 5 in the striatum. J. Comp. Neurol. 520, 570-589 (2012).
4. Chen, J.F. et al. Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation. Prog. Neurobiol. 83, 310-331 (2007).
5. Saura, J. et al. Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J. Neurochem. 95, 919-929 (2005).
6. Orr, A.G., Orr, A.L., Li, X.J., Gross, R.E. & Traynelis, S.F. Adenosine A(2A) receptor mediates microglial process retraction. Nat. Neurosci. 12, 872-878 (2009).
7. +-ATPase-alpha2 controlling glutamate uptake in astrocytes. J. Neurosci. 33, 18492-18502 (2013).
8. Albasanz, J.L., Perez, S., Barrachina, M., Ferrer, I. & Martin, M. Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease. Brain Pathol. 18, 211-219 (2008).
9. Laurent, C. et al. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Mol. Psychiatry published online, doi:10.1038/mp.2014.151 (2 December 2014).
10. Huang, Y. & Mucke, L. Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204-1222 (2012).
11. Heneka, M.T. & O'Banion, M.K. Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 184, 69-91 (2007).
12. Braak, H. & Braak, E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16, 271-278 (1995).
13. Cahoy, J.D. et al. A transcriptome database for astrocytes, neurons and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264-278 (2008).
14. Pickel, V.M., Chan, J., Linden, J. & Rosin, D.L. Subcellular distributions of adenosine A1 and A2A receptors in the rat dorsomedial nucleus of the solitary tract at the level of the area postrema. Synapse 60, 496-509 (2006).
15. Lazarus, M. et al. Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J. Neurosci. 31, 10067-10075 (2011).
16. Bajenaru, M.L. et al. Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol. Cell. Biol. 22, 5100-5113 (2002).
17. Fox, I.J. et al. Developmental expression of glial fibrillary acidic protein mRNA in mouse forebrain germinal zones: implications for stem cell biology. Brain Res. Dev. Brain Res. 153, 121-125 (2004).
18. Karasinska, J.M. et al. ABCA1 influences neuroinflammation and neuronal death. Neurobiol. Dis. 54, 445-455 (2013).
19. Stenzel, D. et al. Integrin-dependent and -independent functions of astrocytic fibronectin in retinal angiogenesis. Development 138, 4451-4463 (2011).
20. Yamanaka, K. et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11, 251-253 (2008).
21. Garcia, A.D., Doan, N.B., Imura, T., Bush, T.G. & Sofroniew, M.V. GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat. Neurosci. 7, 1233-1241 (2004).
22. Matos, M. et al. Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes. Glia 60, 702-716 (2012).
23. Rebola, N., Lujan, R., Cunha, R.A. & Mulle, C. Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses. Neuron 57, 121-134 (2008).
24. Vianna, M.R. et al. Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat. Learn. Mem. 7, 333-340 (2000).
25. Ledent, C. et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388, 674-678 (1997).
26. Bastia, E. et al. A crucial role for forebrain adenosine A(2A) receptors in amphetamine sensitization. Neuropsychopharmacology 30, 891-900 (2005).
27. O'Callaghan, J.P. & Miller, D.B. The concentration of glial fibrillary acidic protein increases with age in the mouse and rat brain. Neurobiol. Aging 12, 171-174 (1991).
28. Wimmer, M.E., Hernandez, P.J., Blackwell, J. & Abel, T. Aging impairs hippocampusdependent long-term memory for object location in mice. Neurobiol. Aging 33, 2220-2224 (2012).
29. Plath, N. et al. Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 52, 437-444 (2006).
30. Alexander, G.M. et al. Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors. Neuron 63, 27-39 (2009).
31. Chang, W.C. et al. Modifying ligand-induced and constitutive signaling of the human 5-HT4 receptor. PLoS ONE 2, e1317 (2007).
32. Halassa, M.M., Fellin, T., Takano, H., Dong, J.H. & Haydon, P.G. Synaptic islands defined by the territory of a single astrocyte. J. Neurosci. 27, 6473-6477 (2007).
33. Bai, X. et al. Genetic background affects human glial fibrillary acidic protein promoter activity. PLoS ONE 8, e66873 (2013).
34. Han, H.J. et al. Strain background influences neurotoxicity and behavioral abnormalities in mice expressing the tetracycline transactivator. J. Neurosci. 32, 10574-10586 (2012).
35. Tse, D. et al. Schemas and memory consolidation. Science 316, 76-82 (2007).
36. Mucke, L. et al. High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050-4058 (2000).
37. Ji, B. et al. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies. J. Neurosci. 28, 12255-12267 (2008).
38. Jankowsky, J.L. et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 13, 159-170 (2004).
39. Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337-351 (2007).
40. Sullivan, P.M. et al. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272, 17972-17980 (1997).
41. Han, J. et al. Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell 148, 1039-1050 (2012).
42. Suzuki, A. et al. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 144, 810-823 (2011).
43. Panatier, A. et al. Glia-derived D-serine controls NMDA receptor activity and synaptic memory. Cell 125, 775-784 (2006).
44. Lee, Y. et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487, 443-448 (2012).
45. Altevogt, B.M. & Paul, D.L. Four classes of intercellular channels between glial cells in the CNS. J. Neurosci. 24, 4313-4323 (2004).
46. Dunwiddie, T.V. & Masino, S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24, 31-55 (2001).
47. Borota, D. et al. Post-study caffeine administration enhances memory consolidation in humans. Nat. Neurosci. 17, 201-203 (2014).
48. Hardt, O., Nader, K. & Nadel, L. Decay happens: the role of active forgetting in memory. Trends Cogn. Sci. 17, 111-120 (2013).
49. Goldman, J.E. & Abramson, B. Cyclic AMP-induced shape changes of astrocytes are accompanied by rapid depolymerization of actin. Brain Res. 528, 189-196 (1990).
50. 2+-activated, CREB-dependent transcription in astrocytes. Glia 57, 828-834 (2009).
51. Chen, J.F. et al. A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19, 9192-9200 (1999).
52. Lin, W. et al. Interferon-gamma induced medulloblastoma in the developing cerebellum. J. Neurosci. 24, 10074-10083 (2004).
53. Conklin, B.R. et al. Engineering GPCR signaling pathways with RASSLs. Nat. Methods 5, 673-678 (2008).
54. Hsiao, E.C. et al. Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass. Proc. Natl. Acad. Sci. USA 105, 1209-1214 (2008).
55. Halassa, M.M. et al. Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 61, 213-219 (2009).
56. Sweger, E.J., Casper, K.B., Scearce-Levie, K., Conklin, B.R. & McCarthy, K.D. Development of hydrocephalus in mice expressing the G(i)-coupled GPCR Ro1 RASSL receptor in astrocytes. J. Neurosci. 27, 2309-2317 (2007).
57. Pascual, O. et al. Astrocytic purinergic signaling coordinates synaptic networks. Science 310, 113-116 (2005).
58. Kawamata, H. et al. Abnormal intracellular calcium signaling and SNARE-dependent exocytosis contributes to SOD1G93A astrocyte-mediated toxicity in amyotrophic lateral sclerosis. J. Neurosci. 34, 2331-2348 (2014).
59. Fujita, T. et al. Neuronal transgene expression in dominant-negative SNARE mice. J. Neurosci. 34, 16594-16604 (2014).
60. Sloan, S.A. & Barres, B.A. Looks can be deceiving: Reconsidering the evidence for gliotransmission. Neuron 84, 1112-1115 (2014).
61. Rockenstein, E.M. et al. Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J. Biol. Chem. 270, 28257-28267 (1995).
62. Palop, J.J. et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55, 697-711 (2007).
63. Sullivan, P.M., Mace, B.E., Maeda, N. & Schmechel, D.E. Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice. Neuroscience 124, 725-733 (2004).
64. Raber, J. et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: Increased susceptibility of females. Proc. Natl. Acad. Sci. USA 95, 10914-10919 (1998).
65. Leung, L. et al. Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice. PLoS ONE 7, e53569 (2012).
66. Colin, A. et al. Engineered lentiviral vector targeting astrocytes in vivo. Glia 57, 667-679 (2009).
67. Shigetomi, E., Kracun, S. & Khakh, B.S. Monitoring astrocyte calcium microdomains with improved membrane targeted GCaMP reporters. Neuron Glia Biol. 6, 183-191 (2010).
68. Zlatkine, P., Mehul, B. & Magee, A.I. Retargeting of cytosolic proteins to the plasma membrane by the Lck protein tyrosine kinase dual acylation motif. J. Cell Sci. 110, 673-679 (1997).
69. Hagemann, T.L., Jobe, E.M. & Messing, A. Genetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survival. PLoS ONE 7, e37304 (2012).
70. Saaltink, D.J., Havik, B., Verissimo, C.S., Lucassen, P.J. & Vreugdenhil, E. Doublecortin and doublecortin-like are expressed in overlapping and non-overlapping neuronal cell population: Implications for neurogenesis. J. Comp. Neurol. 520, 2805-2823 (2012).
71. Spencer, B. et al. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J. Neurosci. 29, 13578-13588 (2009).
72. Marxreiter, F. et al. Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice. Neurobiol. Dis. 59, 38-51 (2013).
73. Piatti, V.C. et al. The timing for neuronal maturation in the adult hippocampus is modulated by local network activity. J. Neurosci. 31, 7715-7728 (2011).
74. Mangin, J.M., Li, P., Scafidi, J. & Gallo, V. Experience-dependent regulation of NG2 progenitors in the developing barrel cortex. Nat. Neurosci. 15, 1192-1194 (2012).
75. Olabarria, M., Noristani, H.N., Verkhratsky, A. & Rodriguez, J.J. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia 58, 831-838 (2010).
76. Nicole, O. et al. Activation of protease-activated receptor-1 triggers astrogliosis after brain injury. J. Neurosci. 25, 4319-4329 (2005).
77. Moritz, A. et al. Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci. Signal. 3, ra64 (2010).
78. Terai, K. et al. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Neuroscience 104, 299-310 (2001).
79. Kir, S. et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature 513, 100-104 (2014).
80. Yiu, A.P., Rashid, A.J. & Josselyn, S.A. Increasing CREB function in the CA1 region of dorsal hippocampus rescues the spatial memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology 36, 2169-2186 (2011).
81. Syme, C.A., Friedman, P.A. & Bisello, A. Parathyroid hormone receptor trafficking contributes to the activation of extracellular signal-regulated kinases but is not required for regulation of cAMP signaling. J. Biol. Chem. 280, 11281-11288 (2005).
82. Sivachandran, N., Sarkari, F. & Frappier, L. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog. 4, e1000170 (2008).
83. Yang, Y. et al. Molecular comparison of GLT1+ and ALDH1L1+ astrocytes in vivo in astroglial reporter mice. Glia 59, 200-207 (2011).
84. Coppieters, N. et al. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain. Neurobiol. Aging 35, 1334-1344 (2014).
85. Kocherhans, S. et al. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice. J. Neurosci. 30, 9228-9240 (2010).